Find More Contacts for Corwave
Protected Content
Manager Operations
2 emails found
View contacts for Corwave to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email contact@corwave.com
  • Phone Number +33(0)1 81 93 50 96

The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action of

the native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system.

Lists Featuring This Company

Health Care Companies With Less Than $1B in Revenue (Top 10K)
9,959 Number of Organizations • $712B Total Funding Amount • 55,889 Number of Investors
Health Care Late Stage Companies With Less Than $50M in Revenue
650 Number of Organizations • $74.6B Total Funding Amount • 6,229 Number of Investors
Medical Device Companies with Late Stage Venture Funding
300 Number of Organizations • $25.6B Total Funding Amount • 2,282 Number of Investors
Ile-de-France Companies With More Than 10 Employees (Top 10K)
9,937 Number of Organizations • $117.7B Total Funding Amount • 10,237 Number of Investors

Frequently Asked Questions

Where is Corwave's headquarters? Corwave is located in Paris, Ile-de-France, France.Who invested in Corwave? Corwave has 12 investors including EXOR N.V. and Bpifrance.How much funding has Corwave raised to date? Corwave has raised .When was the last funding round for Corwave? Corwave closed its last funding round on Jun 20, 2023 from a Series C round.Who are Corwave's competitors? Alternatives and possible competitors to Corwave may include Asklepios BioPharmaceuticalMinerva Surgical, and Altavo.